Skip to main content

NRSN · NeuroSense Therapeutics Ltd. · Analyst Estimates

Track NRSN — free
$0.35 +0.02 (+4.58%) At close · Sep 11
Market Cap
$12.60M
Shares
37.94M

Analyst Estimates

Compare analyst forecasts for NeuroSense Therapeutics Ltd. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Only independently verified consensus published through the company's investor-relations sources is available.

Consensus not yet available

Only independently verified consensus published through the company's investor-relations sources is available.

Key facts CIK 1875091 CUSIP M74240108 13F (30d) 6 filings 6 filers Visit website Investor relations